Aug 2026· Aging Cell· Vol 25· 0 citations· 86 references
Medicine
TL;DR
An accurate, accessible, and ready‐to‐use murine transcriptomic clock that provides robust age predictions for healthy mice using hepatic RNA‐seq data is developed and an increased transcriptomic age in progeroid syndromes is revealed, demonstrating its ability to capture aging‐related biological processes.
Abstract
The increase in life expectancy over the past century has been accompanied by the recognition of age as the primary risk factor for a wide range of pathologies, including cardiovascular and neurodegenerative diseases, as well as cancer. Thus, the development of interventions that slow the underlying biological processes of aging could have beneficial effects on the prevention or progression of these diseases. To evaluate such geroprotective interventions, quantifying biological damage via aging clocks—particularly those based on transcriptomic biomarkers—has become highly relevant, as they provide estimations with strong biological interpretability. However, the limited availability of transcriptomic clocks for murine experimental models has hindered the implementation of these tools in aging research and their use in evaluating interventions that may have geroprotective effects. Here, we have developed an accurate, accessible, and ready‐to‐use murine transcriptomic clock that provides robust age predictions for healthy mice using hepatic RNA‐seq data. Applying the clock to accelerated‐aging models revealed an increased transcriptomic age in progeroid syndromes, demonstrating its ability to capture aging‐related biological processes. Finally, considering the main interest of these tools, we show that well‐established interventions with geroprotective potential, both genetic (Snell Dwarf, Ames Dwarf, and growth hormone receptor‐deficient mice) and environmental (caloric, protein, or methionine restriction, as well as rapamycin supplementation in specific contexts), reduce the transcriptomic age estimated by the clock. These findings indicate that the proposed transcriptomic clock could be a valuable tool for studying the biology of aging and for designing and evaluating potential geroprotective interventions.
Biological age (BA) has been proposed as a complementary construct to chronological age (CA) for quantifying interindividual heterogeneity in aging trajectories. Biological aging clocks (BACs) integrate molecular, clinical and multi-omics biomarkers to estimate aging-related phenotypes beyond CA. This narrative review...
C. Fermín-Martínez, S. Garcia-Gonzalez, Elizabeth Garcia L. Castañeda et al.· Revista de investigacion cli...· 0 citations
Aging is a complex process affected by genes and modified by environment. The forefront of aging research has moved from the level of organisms to the level of tissues and single cells, analyzed using bulk tissue and single-cell transcriptomes. Transcriptomics provides high resolution, comprehensive information per sam...
Stewart A. Frankel, B. Rogina· Frontiers in Genetics· 0 citations
This work constructed a heterogeneous stacked ensemble survival model based on DNAm data obtained from the Framingham Heart Study and constructed a survival prediction model based on the fusion of five complementary survival models by means of a neural network meta-learner.
Muthukumar Yugan Gogul, Karthikeyan A. Vijayakumar, Gwang-Won Cho· Mechanisms of Ageing and Dev...· 0 citations
Aging biomarkers can potentially allow researchers to rapidly monitor the impact of an aging intervention without the need for decade-spanning trials. However, before the use of aging biomarkers, such as epigenetic clocks, as surrogate endpoints, their responsiveness to interventions that target aging must be tested. H...
R. Sehgal, Daniel S. Borrus, J. Armstrong et al.· Nature Medicine· 2 citations